Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.
D000293:Adolescent; D000592:Amino Acid Metabolism, Inborn Errors / Q000235:genetics*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001120:Arginine / Q000097:blood / Q000652:urine; D002746:Chlorpromazine / Q000009:adverse effects; D003555:Cystinuria; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D007408:Intestinal Absorption; D007684:Kidney Tubules / Q000503:physiopathology; D008239:Lysine / Q000097:blood / Q000652:urine; D009069:Movement Disorders / Q000139:chemically induced; D009952:Ornithine / Q000097:blood / Q000652:urine; D010375:Pedigree; D000608:Renal Aminoacidurias / Q000235:genetics* / Q000503:physiopathology; D013881:Thioridazine / Q000009:adverse effects; D014282:Trihexyphenidyl / Q000009:adverse effects
D014150:Antipsychotic Agents; D014282:Trihexyphenidyl; D001120:Arginine; D009952:Ornithine; D008239:Lysine; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine